(3S)-9-benzyl-1-butyl-3-(cyclohexylmethyl)-7-methyl-1,4,9-triazaspiro[5.5]undecane-2,5-dione hydrochloride

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: (3S)-9-benzyl-1-butyl-3-(cyclohexylmethyl)-7-methyl-1,4,9-triazaspiro[5.5]undecane-2,5-dione hydrochloride
• 英文别名: (3S)-9-benzyl-1-butyl-3-(cyclohexylmethyl)-11-methyl-1,4,9-triazaspiro[5.5]undecane-2,5-dione;hydrochloride
• 化学式: C₂₇H₄₁N₃O₂*ClH
• 分子量: 476.102
• InChiKey: GKDVSAUEWQEPEE-SSVLGJNASA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.79
• 重原子数：
  33
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.7
• 拓扑面积：
  52.6
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  在 盐酸 作用下， 以 甲苯 、 乙酸乙酯 为溶剂， 生成 (3S)-9-benzyl-1-butyl-3-(cyclohexylmethyl)-7-methyl-1,4,9-triazaspiro[5.5]undecane-2,5-dione hydrochloride
  参考文献：
  名称：

  EP1621540

  摘要：

  公开号：

文献信息

• NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND USE THEREOF
  申请人：ONO PHARMACEUTICAL CO., LTD.

  公开号：EP1621540A1

  公开（公告）日：2006-02-01

  A pharmaceutical composition comprising, as an active ingredient, the compounds represented by formula (1) (wherein all of the symbols have the same meanings as defined in specification.), salts thereof, solvates thereof, or prodrugs thereof. The compounds represented by formula (I) are used for prevention and/or treatment of various inflammatory diseases (asthma, nephritis, nephropathy, hepatitis, arthritis, chronic rheumatoid arthritis, rhinitis, conjunctivitis, ulcerative colitis and the like), immunologic diseases (treatment of autoimmune diseases, transplant rejection, immunosuppression, psoriasis, multiple sclerosis and the like), human immunodeficiency virus infection (acquired immunodeficiency syndrome and the like), allergic diseases (atopic dermatitis, nettle rash, allergic bronchopulmonary aspergillosis, allergic eosinophilic gastroenteritis and the like), suppression of ischemia-reperfusion injury, acute respiratory distress syndrome, shock accompanied by bacterial infection, diabetes mellitus, or metastasis and the like.

  一种药物组合物，其活性成分包括式 (1) 所代表的化合物 (其中所有符号的含义与说明书中定义的相同）、其盐类、其溶液或其原药。式 (I) 所代表的化合物可用于预防和/或治疗各种炎症性疾病（哮喘、肾炎、肾病、肝炎、关节炎、慢性类风湿性关节炎、鼻炎、结膜炎、溃疡性结肠炎等）、免疫性疾病（治疗自身免疫性疾病、移植排斥、免疫抑制、牛皮癣、多发性硬化等）、人类免疫缺陷病毒感染（获得性免疫缺陷综合征等）、过敏性疾病（特应性皮炎、荨麻疹、过敏性支气管肺曲霉病、过敏性嗜酸性粒细胞性胃肠炎等）、抑制缺血再灌注损伤、急性呼吸窘迫综合征、细菌感染引起的休克、糖尿病或转移等。
• Nitrogen-containing heterocyclic compounds and use thereof
  申请人：Nishizawa Rena

  公开号：US20070155713A1

  公开（公告）日：2007-07-05

  A pharmaceutical composition comprising, as an active ingredient, the compounds represented by formula (I) (wherein all of the symbols have the same meanings as defined in specification.), salts thereof, solvates thereof, or prodrugs thereof. The compounds represented by formula (I) are used for prevention and/or treatment of various inflammatory diseases (asthma, nephritis, nephropathy, hepatitis, arthritis, chronic rheumatoid arthritis, rhinitis, conjunctivitis, ulcerative colitis and the like), immunologic diseases (treatment of autoimmune diseases, transplant rejection, immunosuppression, psoriasis, multiple sclerosis and the like), human immunodeficiency virus infection (acquired immunodeficiency syndrome and the like), allergic diseases (atopic dermatitis, nettle rash, allergic bronchopulmonary aspergillosis, allergic eosinophilic gastroenteritis and the like), suppression of ischemia-reperfusion injury, acute respiratory distress syndrome, shock accompanied by bacterial infection, diabetes mellitus, or metastasis and the like.